Rosa

 Rosaceae

©The World Botanical Associates Web Page
Prepared by Richard W. Spjut
December 2004, Aug 2006

Rosa californica
Peninsular Ranges, CA
Spjut & Marin 14712
Apr 2002

 

Rosa minutifolia
Near San Antonio del Mar, BCN
Mar 1979

 

 

Rosa gymnocarpa

Lake-of-the-Island,
Marble Mts. Wilderness, CA
Mixed fir and pine forest
5600 ft, July 2006

Rosa pisocarpa
Shasta Trinity/Klamath NF, CA
Spjut 14892, July 2002

Rosa woodsii var. ultramontana
Jarbidge, NV, June 2005

 

Nowak R.  2005. Chemical composition of hips essential oils of some Rosa L. species.  Z. Naturforsch. [C]. 60(5-6): 369–378.  “The chemical composition of the hips essential oils of 9 taxa of Rosa L. was analyzed and compared using the standardized analytical GC and GC/MS methods. The volatile hips oil compositions for these species are presented. All oil samples were dominated by following components: vitispiran (isomer), a-E-acaridial, dodecanoic acid, hexadecanoic acid, docosane (C22), beta-ionone, 6-methyl-5-hepten-2-one, 2-heptanone, heptanal, myristic acid and linolic acid. Statistical analyses of 97 GC peaks of these oils were used to distinguish compositional patterns. There appeared to be correlation between the essential oil patterns and the classification within Rosa L. Cluster analysis of the composition of main components clearly showed two groups, one constituted by R. rugosa Thunb. from the Cinnamomea section, and the other constituted by the remaining taxa from the Caninae section.

Park J. C., S. C. Kim, M. R. Choi, S. H. Song, E. J. Yoo, S. H. Kim, H. Miyashiro and M. Hattori.  2005. Anti-HIV protease activity from rosa family plant extracts and rosamultin from Rosa rugosa. J. Med. Food. 8(1): 107–109.  Twelve extracts of Rosa family plants were screened for their inhibitory effects against HIV-1 protease. Of the extracts tested, the strongest inhibitory effects were observed in the root of Rosa rugosa and the leaves of Prunus sargentii, at a concentration of 100 microg/mL. Rosamultin, isolated from the root of R. rugosa, inhibited HIV-1 protease by 53% at a concentration of 100 microM.